Dr. Dana Jean Jamero is a pharmacist who is specialized in Oncology in New Orleans, Louisiana. Patients can reach her at 1 Drexel Dr, New Orleans or contact her on 504-520-5337. Active license number of Dr. Dana Jean Jamero is 16271 for Oncology in Louisiana. Dr. Dana Jean Jamero is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Dana Jean Jamero speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Dana Jean Jamero
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Female
Location:
1 Drexel Dr, New Orleans, Louisiana, 70125-1056
Phone:
504-520-5337
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Dana Jean Jamero are as mentioned below.
NPI Number:
1316074644
NPI Enumeration Date:
27 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Dana Jean Jamero are as mentioned below.
Specialization
License Number
State
Status
Oncology
16271
Louisiana
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 Drexel Dr, New Orleans, Louisiana
Zip:
70125-1056
Phone Number:
504-520-5337
Fax Number:
--
Patients can reach Dr. Dana Jean Jamero at 1 Drexel Dr, New Orleans, Louisiana or can call on phone at 504-520-5337.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.